Princeton Global Asset Management’s NovoCure NVCR Stock Holding History

Princeton Global Asset Management’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-500	Closed	-$56K	–	494
2020 Q3	$56K	Hold	500	–	–	0.02%	209
2020 Q2	$29K	Hold	500	–	–	0.01%	305
2020 Q1	$34K	Sell	500 -300	-38%	-$23.7K	0.02%	256
2019 Q4	$67	Hold	800	–	–	0.03%	219
2019 Q3	$59K	Sell	800 -200	-20%	-$16K	0.03%	192
2019 Q2	$63K	Buy	+1,000	New	+$50.7K	0.04%	196

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Princeton Global Asset Management's NVCR Position: Q4 2020 in Review

Princeton Global Asset Management sold out of NovoCure (NVCR) in Q4 2020, closing a stake of 500 shares — an estimated $56K sold.

Princeton Global Asset Management first reported a position in NVCR in Q2 2019 and held it in 6 quarters. The position peaked at $63K in Q2 2019. 356 funds tracked by Wall St. Rank hold NVCR as of Q4 2020.

Princeton Global Asset Management reported no remaining NovoCure position as of Q4 2020 after selling out during the quarter.
Princeton Global Asset Management sold 500 NovoCure shares in Q4 2020, an estimated $56K.
Princeton Global Asset Management first reported a position in NovoCure in Q2 2019 and held it in 6 quarters.
Princeton Global Asset Management's NovoCure position peaked at $63K in Q2 2019.
356 funds tracked by Wall St. Rank held NovoCure as of Q4 2020.

Based on Princeton Global Asset Management's 13F filing for Q4 2020, filed 9 Feb 2021.